Cytosine arabinoside and mitoxantrone treatment of relapsed or refractory childhood leukemia: Initial response and relationship to multidrug resistance gene 1
- 1 January 1994
- journal article
- research article
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 22 (4) , 244-249
- https://doi.org/10.1002/mpo.2950220406
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- High‐dose cytosine arabinoside and mitoxantrone in previously‐treated acute leukemia patientsEuropean Journal of Haematology, 1990
- AMPLIFICATION OF RNAPublished by Elsevier ,1990
- Mitoxantrone and high-dose cytosine arabinoside for the treatment of refractory acute lymphocytic leukemiaCancer, 1990
- Mitoxantrone and high-dose cytosine arabinoside in refractory acute myelogenous leukemiaCancer, 1988
- Biologic Characteristics and Treatment of Acute Nonlymphocytic Leukemia in Children: Report of the ANLL Strategy Group of the Childrens Cancer Study GroupPediatric Clinics of North America, 1988
- Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids.Proceedings of the National Academy of Sciences, 1986
- Mitoxantrone in the treatment of relapsed and refractory acute leukemiaInvestigational New Drugs, 1985
- A phase II study of mitoxantrone in acute leukemiaInvestigational New Drugs, 1985
- Interactions of antitumor drugs with natural DNA: proton NMR study of binding mode and kineticsJournal of Medicinal Chemistry, 1984
- Drugs Five Years LaterAnnals of Internal Medicine, 1975